This brand name is authorized in Singapore, South Africa
The drug IXEMPRA contains one active pharmaceutical ingredient (API):
|
1
Ixabepilone
UNII K27005NP0A - IXABEPILONE
|
|
Ixabepilone is a semi-synthetic analog of epothilone B, a natural chemical compound produced by Sorangium cellulosum. Epothilones A and B are more potent than the taxanes in their binding of microtubules and in causing cell cycle arrest. Ixabepilone has demonstrated activity in paclitaxel-resistant breast cancer. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01DC04 | Ixabepilone | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DC Other cytotoxic antibiotics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: SG | Health Sciences Authority | Identifier(s): 13599P, 13600P |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 43/26/0913 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
